Screener
Grace Therapeutics, Inc.
GRCEGrace Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing and commercializing therapies for rare and orphan diseases.
$45.02M+6.4%
Earnings
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$1.0M
EPS estimate-$0.15
Competitors
By market cap
Profile
Grace Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing and commercializing therapies for rare and orphan diseases. The company utilizes proprietary drug delivery technologies to reformulate approved pharmaceutical compounds, aiming to improve efficacy, safety, and patient compliance through the FDA's 505(b)(2) regulatory pathway.
Competitive position
Grace Therapeutics positions itself as an innovator in drug delivery for rare diseases, utilizing the 505(b)(2) pathway to reduce development risk and time to market.
GeographiesUnited States, European Union, China
Customer segmentsHealthcare Providers, Specialty Hospitals
Business modelR&D-focused biotechnology, IP Licensing
SuppliersContract Manufacturing Organizations (CMOs), Active Pharmaceutical Ingredient (API) suppliers, Independent clinical research consultants
CustomersTertiary care centers, Comprehensive Stroke Centers, Neurologists, Hospital administrators
CountryUnited States of America
Listed2011
Employees4.0
CEOPrashant Kohli
SectorHealthcare
IndustryBiotechnology
Websiteacastipharma.com
FilingsSEC EDGAR
FAQ
- What is Grace Therapeutics, Inc.'s market cap?
- Grace Therapeutics, Inc. (GRCE) has a market capitalization of $45.0M and trades on XNAS.
- Who are Grace Therapeutics, Inc.'s competitors?
- Grace Therapeutics, Inc.'s key competitors include Fulcrum Therapeutics, Inc. Common Stock, Gain Therapeutics, Inc. Common Stock, Polaryx Therapeutics, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does Grace Therapeutics, Inc. partner with?
- Grace Therapeutics, Inc.'s notable partners include Azurity Pharmaceuticals, Azienda Ospedaliera Universitaria Senese.
- What subsidiaries does Grace Therapeutics, Inc. have?
- Grace Therapeutics, Inc.'s subsidiaries include Grace Therapeutics U.S., Inc..
- Where is Grace Therapeutics, Inc. headquartered?
- Grace Therapeutics, Inc. is headquartered in United States of America and employs approximately 4 people. It has been publicly traded since 2011.